PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Bannon’s War Room | Evening Edition | Recorded July 19, 2021 | Video: 48 Minutes 58 Seconds

Show Me

Biden Continues To Lie About 2020 Election

Show Me

Bannon’s War Room | Saturday Edition Hour 1 | Recorded July 17, 2021 | Video: 48 Minutes 31 Seconds

Show Me

Bannon’s War Room | Saturday Edition Hour 2 | Recorded July 17, 2021 | Video: 48 Minutes 17 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded July 16, 2021 | Video: 48 Minutes 43 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded July 16, 2021 | Video: 48 Minutes 38 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded July 16, 2021 | Video: 48 Minutes 58 Seconds

Show Me

June 25, 2021 | Nightly News Rebroadcast | Video: 54 Minutes 23 Seconds

Show Me

FLASHBACK: Demon Joe Biden Broke into US Capitol and Was Arrested — Now He Holds Hundreds of Trump Supporters in Isolation in Prison Without Trial for Very Same Crime (VIDEO)

Show Me

Democratic Party Won’t Admit It’s Become the Party of Wealth

Show Me

59 of 96 Phones Assigned to Robert Mueller Probe Missing: GOP Senators

Show Me

Federal agents arrest, turn back record 188,800 immigrants at southern border, report

Show Me

Breyer, Top Liberal Supreme Court Justice, Says He Hasn’t Decided on Retirement

Show Me

Privacy Is Still a Victim When Rape Cases Hit the Justice System

Show Me

House Democrat-led Jan. 6 select panel schedules first hearing

Show Me

Former Harris Campaign Official Launches Group To Advise Companies On Social Justice Issues

Show Me

Tucker Carlson Airs HARD EVIDENCE of Voter Fraud in Fulton County That Could Alter Election 2020

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded July 15, 2021 | Video: 48 Minutes 45 Seconds

Show Me

Lightning Strike Destroys George Floyd Mural

Show Me

U.S. Military Leadership’s Slow Descent Into Madness | “Joint Chiefs Chairman Compared Trump to Hitler, MAGA to Nazi ‘Brownshirts'”

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded July 15, 2021 | Video: 48 Minutes 51 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded July 15, 2021 | Video: 48 Minutes 58 Seconds

Show Me

Who Killed Whitey Bulger New Details Emerge On Possible Attacker | TODAY | Video: 3 Minutes 1 Second

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded July 14, 2021 | Video: 48 Minutes 53 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded July 14, 2021 | Video: 48 Minutes 53 Seconds

Show Me

Whitey Bulger Allowed To rob, Extort And Murder With The FBI’s Assistance | 60 Minutes | Video: 13 Minutes 29 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded July 14, 2021 | Video: 48 Minutes 58 Seconds

Show Me

The FBI Wants American Families To Spy On Each Other? | “This Is Why I Refuse To Trust The FBI” ~ Don Bongino, Former Secret Service Agent | Video: 8 Minutes 57 Seconds

Show Me

Once Corrupt, Always Corrupt | Is It Time to Abolish the FBI? | Video: 5 Minutes 29 Seconds

Show Me

Former Acting Director of National Intelligence, Ric Grennell On The FBI’s NAZI-like and Stalinist Call For Families To Spy On Each Other – “Outrageous”

Show Me

And The FBI Wants Families To Turn In Good Loving Americans While Brutal Murders Happen In Urban Cities On A Daily Basis | Video: 23 Seconds

Show Me

“I’m a patriot and I love this nation. And I believe in the people standing up against the government in the correct way. So, if that makes me radical and an extremist, so be it.” ~ Former Navy Seal Jonathan Gilliam | FBI Asks Americans to Report their Friends, Family | Video: 5 Minutes 40 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded July 13, 2021 | Video: 48 Minutes 20 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded July 13, 2021 | Video: 48 Minutes 48 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded July 13, 2021 | Video: 48 Minutes 58 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded July 12, 2021 | Video: 48 Minutes 23 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded July 12, 2021 | Video: 48 Minutes 51 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded July 12, 2021 | Video: 48 Minutes 57 Seconds

Show Me

A Covid Test as Easy as Breathing

Show Me

21 Countries Demand China End Attack on Press Freedom in Hong Kong

Show Me